These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 7221185

  • 1. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T, Hirokawa N, Oike S, Maekawa T.
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [Abstract] [Full Text] [Related]

  • 2. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)].
    Gibey R, Dupond JL, Peltier H, Iehl-Robert M, Henry JC.
    Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703
    [Abstract] [Full Text] [Related]

  • 3. [Influence of aminoglycosides on the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes].
    Mozer JL, Gibey R, Dupond JL, Henry JC.
    Pathol Biol (Paris); 1988 Mar; 36(3):230-4. PubMed ID: 3283685
    [Abstract] [Full Text] [Related]

  • 4. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C, Bosomworth M, Clifton I, Peckham DG, Conway SP.
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [Abstract] [Full Text] [Related]

  • 5. N-acetyl-beta-D-glucosaminidase enzymuria as an indicator in monitoring the therapy of some rheumatic diseases with potentially nephrotoxic drugs.
    Wiland P, Szechiński J.
    Arch Immunol Ther Exp (Warsz); 1994 Jan; 42(4):331-6. PubMed ID: 7487376
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of gentamicin, amikacin and dactimicin on excretion of N-acetyl-beta-D-glucosaminidase (NAG) and kidney histological pattern in rats.
    Palla R, Paternoster G, Galigani P, Giovannini L, Bertelli AA, Romano MR, Alessandrì MG, Bertelli A.
    Drugs Exp Clin Res; 1987 Jan; 13(12):751-6. PubMed ID: 3447879
    [Abstract] [Full Text] [Related]

  • 7. Proximal tubule damage in patients treated with gentamicin or amikacin.
    Wiland P, Szechciński J.
    Pol J Pharmacol; 2003 Jan; 55(4):631-7. PubMed ID: 14581723
    [Abstract] [Full Text] [Related]

  • 8. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics].
    Gibey R, Dupond JL, Mallet H, Guerber F, Iehl-Robert M, Flausse-Parrot F, Becker M.
    Nephrologie; 1986 Jan; 7(2):51-5. PubMed ID: 3736764
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effect of aminoglycosides on excretion of N-acetyl-beta-glucosaminidase.
    Fujita K, Murayama T, Kawamura M, Narita K.
    Int J Clin Pharmacol Res; 1987 Jan; 7(6):477-80. PubMed ID: 3440638
    [Abstract] [Full Text] [Related]

  • 10. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 10. Clinical significance of urinary NAG activity in patients with kidney diseases, with special reference to nephrotic syndrome and antibiotic treatment].
    Ishimoto F, Shibazaki T, Murai S, Kodama K, Ohno I, Gomi H.
    Rinsho Byori; 1983 Sep; Spec No 56():147-59. PubMed ID: 6663756
    [No Abstract] [Full Text] [Related]

  • 11. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in aminoglycoside nephrotoxicity.
    Assadamongkol K, Tapaneya-Olarn W, Chatasingh S.
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():42-6. PubMed ID: 2732646
    [Abstract] [Full Text] [Related]

  • 12. Urinary N-acetyl-beta-D-glucosaminidase (NAG) isoenzyme profiles: a tool for evaluating nephrotoxicity of aminoglycosides and cephalosporins.
    Gibey R, Dupond JL, Henry JC.
    Clin Chim Acta; 1984 Feb 14; 137(1):1-11. PubMed ID: 6697524
    [Abstract] [Full Text] [Related]

  • 13. Enzymuria determination in children treated with aminoglycosides drugs.
    Mohammadi-Karakani A, Asgharzadeh-Haghighi S, Ghazi-Khansari M, Seyed-Ebrahimi A, Ghasemi A, Jabari E.
    Hum Exp Toxicol; 2008 Dec 14; 27(12):879-82. PubMed ID: 19273542
    [Abstract] [Full Text] [Related]

  • 14. Nephrotoxicity of aminoglycosides and cephalosporins in combination.
    Rankin GO, Sutherland CH.
    Adverse Drug React Acute Poisoning Rev; 1989 Dec 14; 8(2):73-88. PubMed ID: 2672726
    [Abstract] [Full Text] [Related]

  • 15. Asymptomatic primary hyper- N-acetyl-beta-D-glucosaminidaseuria: a new clinical entity?
    Asami T, Soichiro O, Kasahara T, Uchiyama M.
    Pediatr Nephrol; 2002 Jul 14; 17(7):560-5. PubMed ID: 12172776
    [Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of urinary n-acetyl-beta-d-glucosaminidase activity in patients treated with aminoglycosides].
    Hirokawa N, Naruse T.
    Nihon Jinzo Gakkai Shi; 1982 Sep 14; 24(9):1041-53. PubMed ID: 7161951
    [No Abstract] [Full Text] [Related]

  • 17. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
    Ali-Miraftab H, Bourbouze R, Bondiou MT, Percheron F.
    Pathol Biol (Paris); 1988 Mar 14; 36(3):240-4. PubMed ID: 3283687
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 9. Clinical study of urinary NAG activity in patients with various kidney diseases].
    Suzuki M, Asano Y.
    Rinsho Byori; 1983 Sep 14; Spec No 56():139-46. PubMed ID: 6663755
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.